Results 221 to 230 of about 87,349 (342)

Enfortumab vedotin plus pembrolizumab in treatment‐naïve metastatic urothelial carcinoma patients: An Austrian real‐world analysis

International Journal of Cancer, Volume 158, Issue 6, Page 1654-1665, 15 March 2026.
What's new? New antibody‐drug conjugates (ADCs) and immunotherapies have helped expand treatment options for urothelial carcinoma (UC). Clinical trials suggest that the ADC enfortumab vedotin (EV) and the immunotherapeutic agent pembrolizumab, when used in combination, are especially effective against UC.
Dora Niedersuess‐Beke, Karl Mayrhofer, Johanna Krauter, Johannes Franke, Dominic Vais, Maximillian Pallauf, David Kiesl, Ferdinand Luger, Jacob Pfuner, Angelika Terbuch, Thomas Bauernhofer, Jasmin Spielgelberg, Andreas Banner, Stefan Aufderklamm, Clemens Wiesinger, Susanne Schnabel, Simon Peter Gampenrieder, Josef Mühlmann, Sonia Vallet, Sabine Weibrecht, Franz Stoiber, Haleh Andalibi, Harun Fajkovic, Hossein Taghizadeh, Jan Miechowiecki, Roman Taedcke, Daniel Heintel, Shahrokh F. Shariat, Martin Pichler, Wolfgang Hilbe, Renate Pichler   +30 more
wiley   +1 more source

<i>Cis</i>-regulatory elements operating in the trophoblast. [PDF]

Front Cell Dev Biol
Vcelkova T, Latos PA.
europepmc   +1 more source

Potential Targets and Biomarkers of Radionuclide Therapy in Breast Cancer

Cancer Innovation, Volume 5, Issue 1, February 2026.
Potential biomarkers for the development of targeted radionuclide therapy that can be employed in the treatment of breast cancer have been summarised in the review. They include receptor markers of ER, PR and HER2, as well as other markers of Trop2, PD‐1, EGFR, GRPR and PSMA.
Yujing Tan, Cheng Zeng, Jiani Wang, Fei Ma   +3 more
wiley   +1 more source

VGLL1 contributes to both the transcriptome and epigenome of the developing trophoblast compartment. [PDF]

Proc Natl Acad Sci U S A
Calderon RI, Sah N, Huang M, Kallol S, Kittle RH, Shaik WB, Abdelbaki A, Chousal JN, Morey R, Bui T, Mitre A, Fogarty NME, Gerri C, Manalo Z, Zheng C, De Hoff P, Home P, Niakan KK, Cook-Andersen H, Fisch KM, Paul S, Soncin F.   +21 more
europepmc   +1 more source

Free Fetal Haemoglobin in Severe Early‐Onset Fetal Growth Restriction: A Prospective Multi‐Centre Study

BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 3, Page 401-411, February 2026.
ABSTRACT Objective To assess fetal circulating free fetal haemoglobin (fHbF) levels and heme defences, correlated to fetal circulatory biometry and fetal sex in severe early‐onset fetal growth restriction (FGR). Design, Setting and Population A prospective study severe early‐onset fetal growth restriction pregnancies with close clinical management ...
Adam Brook, Georgia Baynes, Jonathan Scargill, Angelos Evangelinos, Charlotte Brennan‐Richardson, Freya Dow, Yuval Ginsberg, Tal Weissbach, Jana Brodszki, Eva Hansson, Anke Diemert, Kurt Hecher, Katarzyna Maksym, Neil Marlow, Rebecca N. Spencer, Anna L. David, Stefan R. Hansson, Paul Brownbill   +17 more
wiley   +1 more source

Exiting the ground state: the broad spectrum of cell fates accessible from naïve human pluripotent stem cells. [PDF]

Cell Mol Life Sci
Park KM, Yin R, Theunissen TW.
europepmc   +1 more source

Effects of interleukin-6 on extravillous trophoblast invasion in early human pregnancy [PDF]

, 2012
Hedele Champion, Barbara A. Innes, Stephen C. Robson, Gendie E. Lash, Judith N. Bulmer   +4 more
openalex   +1 more source

Pregnancy and Delivery Outcomes in Vascular Ehlers–Danlos Syndrome: A Retrospective Multicentre Cohort Study

BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 3, Page 463-470, February 2026.
ABSTRACT Objective We aim to increase knowledge on pregnancy and delivery risks in vascular Ehlers–Danlos Syndrome (vEDS). Our outcomes can contribute to establishing future guidelines for pregnancy and delivery management in women with vEDS. Design Retrospective multicentre cohort study.
Lisa M. van den Bersselaar, Ingrid M. B. H. van de Laar, Marieke J. H. Baars, Annette Baas, Eelco Dulfer, Apollonia T. J. M. Helderman‐van den Enden, Yvonne Hilhorst‐Hofstee, Robert M. Kauling, Marlies J. E. Kempers, Martijn A. Oudijk, Alessandra Maugeri, Hennie T. Brüggenwirth, Arjan C. Houweling, Serwet Demirdas   +13 more
wiley   +1 more source

Unraveling the impact of hsa-miR-518c-5p on placental health: mechanistic insights into preeclampsia pathogenesis. [PDF]

J Transl Med
Chen L, Jie Q, Jiang W, Cheng Z, Zhang L, Pang M, Wang Y, Huang L, Zhong M, Ma Y, Yue X.   +10 more
europepmc   +1 more source

Gestational Trophoblastic Neoplasia [PDF]

CA: A Cancer Journal for Clinicians, 1983
openaire   +2 more sources